Methodology
The enrolled sample population were randomized into experimental and
control groups using computer generated block of four with allocation
concealment. Sucralfate was then distributed only to the randomized
experimental group on postoperative day0. All patients were instructed
and assigned the same analgesic protocol. Study participants were then
scheduled for wound assessment and VAS score collection at day7 and
day14.
Initially, 43 enrolled patients were assessed for eligibility, 10
patients were excluded due to enrollment criteria and 3 patients
declined voluntarily participation, resulting in final enrollment of 30
patients included in the study and randomized into. Control group (n=16)
and Sucralfate group (n=14). In the control group, 3 patients were lost
to contact, 4 patients were lost to wound assessment follow up at day7
and 3 patients were lost to wound assessment follow up at day14. In the
Sucralfate group, 1 patient was lost to contact, 5 patients were lost to
wound assessment follow up at day7, and 1 patient lost to wound
assessment follow up at day14. Collected data was then analysed and
reported in reference to CONSORT guideline.